NPPA issues revised calculation sheet for ceiling price of antibiotic injection following review order: Gireesh Babu, New Delhi Saturday, December 21, 2024, 08:00 Hrs [IST] The Na ...

Cipla shares gained over 2 percent on December 17 after Kotak Institutional Equities upgraded the stock to a 'buy' from its previous 'add' rating. The upgrade was driven by factors such as ...

Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar ... binding offer by early October. Suven said Advent would make an additional open offer for up to 26 per cent ...

Shares of Cipla gained nearly 2 per cent on Monday, following the United States Food and Drug Administration (USFDA) classifying its Goa facility as “Voluntary Action Indicated” (VAI ...

A total of 1.39 crore shares of Cipla Ltd, representing 1.72 percent of the company’s equity, were sold through block deals on Monday. Promoters are the likely sellers, as reported previously by ...

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...